肺炎診斷市場規模、佔有率和成長分析：按檢測類型、病原體類型、最終用戶、檢體類型、技術和地區分類－2026-2033年產業預測

2024 年全球肺炎診斷市場價值為 27.4 億美元，預計到 2025 年將成長至 29.6 億美元，到 2033 年將成長至 54.3 億美元，在預測期（2026-2033 年）內複合年成長率為 7.9%。

全球肺炎診斷市場涵蓋分子PCR試劑盒和抗原檢測套組等產品，這些產品對於檢測細菌和病毒性肺部感染疾病至關重要。肺炎對發病率和死亡率影響巨大，尤其是在弱勢群體中，因此這些產品至關重要。目前，人們正從傳統的培養方法轉向先進的分子診斷平台，這推動了對快速可靠檢測的需求。多重檢測系統的引入大幅縮短了診斷時間，從而能夠更快地做出臨床決策。監管機構為支持合理使用抗生素所採取的措施也推動了市場成長。醫院被鼓勵採用能夠準確區分病原體的快速檢測方法，從而降低抗藥性和治療成本。因此，這一趨勢正在加速保險公司對創新檢測方法的承保，並鼓勵製造商將診斷技術推廣到資源匱乏的地區，最終擴大市場覆蓋範圍。

全球肺炎診斷市場成長要素

全球公共衛生標準提升的努力凸顯了早期發現呼吸道感染疾病的重要性，促使衛生部門將肺炎篩檢納入標準醫療實踐。這項轉變推動了醫護人員採用快速診斷方案的意願，從而增加了對可靠且易於使用的檢測方法的需求。臨床醫生和患者意識的提高加深了對及時診斷益處的認知，促進了創新獎勵技術在各種醫療機構中的應用。此外，扶持政策激勵私立診所提升診斷能力，進而推動了市場上對尖端檢測套組的需求。

全球肺炎診斷市場面臨的限制因素

分子診斷平台的高成本是許多醫療機構面臨的主要障礙。在資源匱乏的環境中，這種影響尤其顯著，因為資金限制使得必要的設備難以購買。試劑和維護合約的高昂價格進一步加重了經濟負擔，迫使醫療機構將預算分配給基礎醫療服務，而非投資先進的肺炎診斷工具。這種對成本的敏感度阻礙了創新檢測技術的廣泛應用，最終抑制了市場成長，並限制了快速疾病檢測的普及。因此，資金限制顯著影響了醫療機構採用高效能診斷解決方案。

全球肺炎診斷市場趨勢

全球肺炎診斷市場正經歷著快速床邊診斷技術顯著轉變的趨勢。這一趨勢的驅動力源於臨床環境中對快速決策日益成長的需求，旨在縮短住院時間並改善患者照護。攜帶式且易於使用的診斷設備使醫護人員能夠在床邊進行檢測，從而顯著減少檢體運輸造成的延誤。這種能力不僅有助於及時合理地使用抗生素，還能提高早期啟動治療的可能性。臨床醫生越來越傾向於採用這些解決方案，尤其是在缺乏傳統實驗室基礎設施的急診和基層醫療機構，最終將改善患者預後並提高醫療機構的運作效率。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球肺炎診斷市場規模：依檢測類型分類

• 分子診斷
• 免疫診斷
• 微生物培養
• 診斷影像

全球肺炎診斷市場規模：按病原體類型分類

• 細菌性肺炎
• 病毒性肺炎
• 黴菌性肺炎

全球肺炎診斷市場規模：依最終用戶分類

• 醫院
• 診斷檢查室
• 照護端環境

全球肺炎診斷市場規模：依樣本類型分類

• 血
• 痰
• 鼻咽拭子
• 支氣管肺泡灌洗

全球肺炎診斷市場規模：依技術分類

• PCR
• 免疫檢測
• 次世代定序
• 影像系統

全球肺炎診斷市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• bioMerieux SA
• QIAGEN NV
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Sysmex Corporation
• Hologic, Inc.
• Seegene Inc.
• QuidelOrtho Corporation
• Werfen SA
• Trinity Biotech plc
• Diasorin SpA
• Cepheid
• OraSure Technologies, Inc.
• Luminex Corporation
• Agilent Technologies, Inc.

結論與建議

Global Pneumonia Diagnostics Market size was valued at USD 2.74 Billion in 2024 and is poised to grow from USD 2.96 Billion in 2025 to USD 5.43 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

The global pneumonia diagnostics market encompasses products like molecular PCR kits and antigen assays essential for detecting bacterial and viral lung infections, crucial due to pneumonia's significant morbidity and mortality impacts, particularly among vulnerable populations. There has been a noticeable shift from traditional culture-based methods to advanced molecular platforms, highlighting the demand for rapid, reliable testing. The introduction of multiplex testing systems has drastically shortened diagnostic turnaround times, enabling quicker clinical decision-making. This market experiences growth driven by regulatory initiatives supporting antimicrobial stewardship. Hospitals are incentivized to implement rapid tests that accurately differentiate pathogens, leading to reduced drug resistance and treatment costs. Consequently, this dynamic encourages payers to reimburse innovative assays, prompting manufacturers to extend accessible diagnostics to under-resourced areas, ultimately broadening market reach.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pneumonia Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pneumonia Diagnostics Market Segments Analysis

Global pneumonia diagnostics market is segmented by test type, pathogen type, end user, sample type, technology and region. Based on test type, the market is segmented into molecular diagnostics, immunodiagnostics, microbiological culture and imaging. Based on pathogen type, the market is segmented into bacterial pneumonia, viral pneumonia and fungal pneumonia. Based on end user, the market is segmented into hospitals, diagnostic laboratories and point-of-care settings. Based on sample type, the market is segmented into blood, sputum, nasopharyngeal swab and bronchoalveolar lavage. Based on technology, the market is segmented into PCR, immunoassay, next-generation sequencing and imaging systems. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pneumonia Diagnostics Market

The global drive for enhanced public health standards emphasizes the importance of early detection of respiratory infections, leading health authorities to integrate pneumonia screening into standard care practices. This transformation motivates healthcare professionals to implement rapid diagnostic solutions, heightening the need for reliable and user-friendly testing options. Increased awareness among both clinicians and patients enhances the recognition of the benefits associated with timely diagnoses, promoting the acceptance and utilization of innovative diagnostic technologies across various healthcare settings. Furthermore, supportive policies incentivize private clinics to enhance their diagnostic capabilities, bolstering the demand for cutting-edge testing kits in the market.

Restraints in the Global Pneumonia Diagnostics Market

The elevated cost associated with molecular diagnostic platforms creates a significant obstacle for numerous healthcare providers, especially in low-resource environments where financial limitations hinder the acquisition of necessary equipment. The high prices of reagents and maintenance agreements further exacerbate the financial strain, leading institutions to allocate their budgets towards fundamental healthcare services rather than investing in advanced pneumonia diagnostic tools. This sensitivity to costs hampers the broader adoption of innovative testing technologies, ultimately stalling market growth and limiting access to prompt disease detection. As a result, financial constraints greatly influence the deployment of high-performance diagnostic solutions within the healthcare landscape.

Market Trends of the Global Pneumonia Diagnostics Market

The Global Pneumonia Diagnostics market is witnessing a notable shift towards the adoption of rapid point-of-care diagnostic technologies. This trend is fueled by the increasing demand for prompt decision-making in clinical settings, aimed at reducing hospital stay durations and improving patient care. With portable and user-friendly diagnostic devices, healthcare providers can perform bedside testing, significantly cutting down sample transport delays. This capability not only supports timely antimicrobial stewardship but also enhances the capacity for early treatment initiation. Clinicians are increasingly drawn to these solutions, particularly in emergency and primary care environments, where traditional laboratory infrastructure may be lacking, ultimately leading to improved patient outcomes and operational efficiency in healthcare facilities.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Pneumonia Diagnostics Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Molecular Diagnostics
• Immunodiagnostics
• Microbiological Culture
• Imaging

Global Pneumonia Diagnostics Market Size by Pathogen Type & CAGR (2026-2033)

• Market Overview
• Bacterial Pneumonia
• Viral Pneumonia
• Fungal Pneumonia

Global Pneumonia Diagnostics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Point-of-Care Settings

Global Pneumonia Diagnostics Market Size by Sample Type & CAGR (2026-2033)

• Market Overview
• Blood
• Sputum
• Nasopharyngeal Swab
• Bronchoalveolar Lavage

Global Pneumonia Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• PCR
• Immunoassay
• Next-Generation Sequencing
• Imaging Systems

Global Pneumonia Diagnostics Market Size & CAGR (2026-2033)

• North America (Test Type, Pathogen Type, End User, Sample Type, Technology)
  • US
  • Canada
• Europe (Test Type, Pathogen Type, End User, Sample Type, Technology)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Pathogen Type, End User, Sample Type, Technology)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Pathogen Type, End User, Sample Type, Technology)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Pathogen Type, End User, Sample Type, Technology)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Werfen S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diasorin S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OraSure Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations